IDEXX Laboratories Inc
IDXX- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000874716
In the last 90 days, IDEXX Laboratories Inc insiders filed 0 open-market purchases and 1 sale; 1,306 institutions reported holding it in 13F filings for Q2 2026, worth $39.1B in total; 3 superinvestors hold it, including Fundsmith and Weitz Investment Management.
Q3 2023 vs. Q2 2023
How the institutions holding IDEXX Laboratories Inc changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 1,069 | 12 | 1,061 | +4 |
| Shares | 73.1M | 498.7K | 74.0M | +1.41M (+1.9%) |
| Value | $36.7B | $250.4M | $32.4B | −$4.06B (−11.1%) |
12 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (89)
Institutions that held IDEXX Laboratories Inc at the end of Q3 2023 but not at the end of Q2 2023.
Sold out (85)
Institutions that held IDEXX Laboratories Inc at the end of Q2 2023 and filed for Q3 2023 without it.
Not filed for Q3 2023 yet (12)
Institutions that held IDEXX Laboratories Inc at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Pictet Asset Management SA | 350,244 | $175.9M |
| Kames Capital plc | 68,181 | $34.2M |
| Tekla Capital Management LLC | 58,595 | $29.4M |
| Efg Capital International Corp. | 12,841 | $6.45M |
| Kistler-Tiffany Companies, LLC | 4,014 | $2.02M |
| Tiaa, FSB | 2,182 | $1.10M |
| BerganKDV Wealth Management, LLC | 870 | $436.9K |
| EA Series Trust | 554 | $278.2K |
| PFS Investments Inc. | 536 | $269.0K |
| Vigilant Capital Management, LLC | 339 | $170.0K |
| Endurance Wealth Management, Inc. | 287 | $144.0K |
| First Capital Advisors Group, LLC. | 29 | $14.6K |